Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 800
Avg Vol 20,306
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 68%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERI...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 4 1229 2977
Address:
Australia Square, Level 14 264-278 George Street, Sydney, Australia
Latest News on NXSCF
No data available.